Bailey Gregory's Form 4 filing
Serina Therapeutics, Inc. (SER) · filed Aug 20, 2024
- Accession no.
- 0001493152-24-033277
- Filed
- Aug 20, 2024
- Trade date
- Aug 15-19, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $140.1K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bailey GregoryCIK 0001329505 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 | Common Stock | PPurchaseAcquired | +6,400 | $6.65 | +$42,560 | 33,006 | Direct | |
| Aug 16, 2024 | Common Stock | PPurchaseAcquired | +6,400 | $7.31 | +$46,784 | 39,406 | Direct | |
| Aug 19, 2024 | Common Stock | PPurchaseAcquired | +6,400 | $7.93 | +$50,752 | 45,806 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.